391912-79-1

Basic information

• Product Name: [4-(4-Dimethylamino-butoxy)-phenyl]-methyl-carbamic acid 4-chloro-phenyl ester; compound with formic acid
• Synonyms: [4-(4-Dimethylamino-butoxy)-phenyl]-methyl-carbamic acid 4-chloro-phenyl ester; compound with formic acid
• CAS NO: 391912-79-1
• Molecular Weight: 422.909
• Mol File: 391912-79-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [4-(4-Dimethylamino-butoxy)-phenyl]-methyl-carbamic acid 4-chloro-phenyl ester; compound with formic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(4-Dimethylamino-butoxy)-phenyl]-methyl-carbamic acid 4-chloro-phenyl ester; compound with formic acid(391912-79-1)
• EPA Substance Registry System: [4-(4-Dimethylamino-butoxy)-phenyl]-methyl-carbamic acid 4-chloro-phenyl ester; compound with formic acid(391912-79-1)

Safety Data

• Hazardous Substances Data: 391912-79-1(Hazardous Substances Data)

Upstream product

• 391912-69-9 [4-(4-Bromo-butoxy)-phenyl]-methyl-carbamic acid 4-chloro-phenyl ester 

Relevant articles and documents

Analine derivatives as OSC inhibitors

The present invention relates to compounds of formula (I) wherein U, Y, V, W, L, X, A1, A2, A3, A4, A5 and A6 are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, and/or treatment and/or prophylaxis of impaired glucose tolerance and diabetes.